QNRX offering history
Every offering-related filing in Quoin Pharmaceuticals, Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 557 filings back to Apr 8, 2016.
| Date | Filing | What it means | |
|---|---|---|---|
| Jun 2, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 5, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 4, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 7, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 15, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 3, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 23, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Dec 20, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 18, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 11, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 11, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Nov 8, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 12, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 10, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 8, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 3, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 8, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 8, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 6, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Mar 4, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 14, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 13, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 12, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jan 31, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 30, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 18, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 9, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 7, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 1, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 14, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 3, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jul 18, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 28, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 12, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 9, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 7, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 22, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 17, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 28, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 28, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
QNRX offering FAQ
When did QNRX last execute an offering?
Per SEC filings, Quoin Pharmaceuticals, Ltd.'s most recent priced offering document is a 8-K filed 2025-10-15. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did QNRX last announce or register an offering?
The most recent registration is a S-3 filed 2025-11-07. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.